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Mitochondrial gene expression is a fundamental process that
is largely dependent on nuclear-encoded proteins. Several
steps ofmitochondrial RNAprocessing andmaturation, includ-
ing RNA post-transcriptional modification, appear to be spa-
tially organized into distinct foci, which we have previously
termed mitochondrial RNA granules (MRGs). Although an
increasing number of proteins have been localized to MRGs, a
comprehensive analysis of the proteome of these structures
is still lacking. Here, we have applied a microscopy-based
approach that has allowed us to identify novel components of
the MRG proteome. Among these, we have focused our atten-
tion on RPUSD4, an uncharacterized mitochondrial putative
pseudouridine synthase.We show that RPUSD4 depletion leads
to a severe reduction of the steady-state level of the 16S mito-
chondrial (mt) rRNA with defects in the biogenesis of the mito-
ribosome large subunit and consequently in mitochondrial
translation. We report that RPUSD4 binds 16S mt-rRNA, mt-
tRNAMet, and mt-tRNAPhe, and we demonstrate that it is
responsible for pseudouridylation of the latter. These data pro-
vide new insights into the relevance of RNA pseudouridylation
in mitochondrial gene expression.
Gene expression in mitochondria is a unique and complex
process that requires tightly coordinated expression of the
mitochondrial and nuclear genomes to allow the biogenesis of
the electron transport chain and of the ATP synthase. This
oxidative phosphorylation (OXPHOS)3 system is themain pro-
ducer of ATP in cells and in humans is composed of around 100
proteins of which 13 of the most hydrophobic components are
encoded by the mitochondrial DNA (mtDNA). In addition, the
minimalmitochondrial genome encodes 22mt-tRNAs and two
mt-rRNAs (12S and 16S) essential for protein synthesis inmito-
chondria. All the other proteins involved in mtRNA synthesis
and processing, translation, and post-translational modifica-
tion of the mitochondrial gene products are encoded in the
nucleus and imported from the cytosol to exert their functions
(1).Mutations inmany of the genes encoding these proteins (2),
as well asmutations in themtDNA, have been associated with a
highly heterogeneous group of severe human pathologies for
which the search for efficient treatment strategies remains a
major challenge (3).
Both strands of the mtDNA are transcribed in the form of
long polycistronic precursor RNAs, which are then processed
to release the individual mt-tRNAs, mt-rRNAs, and mt-mRNAs
(4, 5). These different RNA species are variously modified dur-
ing or after transcription by, for example, polyadenylation, meth-
ylation, pseudouridylation, and, in the case of tRNAs, CCA
addition and aminoacylation. Although less well characterized
than other types of RNA modifications, pseudouridine ( or
5-ribosyluracil) was the first to be discovered and is the most
abundant RNA modification described thus far. It is generated
through uridine-specific isomerization, resulting in the forma-
tion of an extra hydrogen bond donor at its non-Watson-Crick
edge (6). As a consequence, the presence of pseudouridine gen-
erally rigidifies RNA secondary structures; thus it has been pro-
posed to contribute toward the stabilization of a particular
structural motif. Accordingly, pseudouridylation is found pre-
dominantly in tRNAs, rRNAs, and other small non-coding
RNAs (7) for which proper structure is critical for function. In
humans, 13 different pseudouridine synthases have been iden-
tified. Of these 13 enzymes, five have been shown (PUS1) or
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predicted (PUSL1, TRUB2, RPUSD3, and RPUSD4) to localize
tomitochondria (8, 9). Pseudouridine has been found at several
highly conserved sites in bovine mt-tRNAs (10) as well as at
position 1397 of the human 16S mt-rRNA (11, 12). To date,
more is known about the general role of pseudouridylation in
mitochondria than about the enzymes responsible for it. The
only exception in humans is PUS1, which is responsible for the
formation of27 and28 in a subset of mt-tRNAs with loss of
function mutations of this enzyme having been identified in
patients presenting myopathy, lactic acidosis, and sideroblastic
anemia (13). The four remaining mitochondrial pseudouridine
synthases are still uncharacterized, and their pseudouridylation
target sites have yet to be assigned.
The various stages of mt-RNA processing in mitochondria
appear to be spatially organized within foci, named mitochon-
drial RNA granules (MRGs). The existence of mitochondrial
foci containing newly synthesized RNA was first reported by
Iborra et al. (14). However, little attention was given to these
compartments until more recently when some groups, includ-
ing ours, reported that a number of proteins involved in
mtRNA processing, mitoribosome subunit assembly, and
translation-associated factors was also found to localize in
these structures (for a review, see Ref. 15). The identification
of such a panel of MRG-associated proteins led us to conclude
that many, if not all, stages of mitochondrial gene expression
are centered on these granules. However, due to the technical
challenges inherent in the purification of intact MRGs, a com-
plete description of their proteome is yet to be established.
Thanks to the small scale of mitochondrial proteome, here
we have expressed several potential mitochondrial RNA-bind-
ing proteins and identified novel MRG components using a
microscopy-based approach. Among these, we have chosen to
focus our attention on the hitherto uncharacterized putative
mitochondrial pseudouridine synthase, RPUSD4. We show
that RPUSD4 is an essential gene in human cells and that its
silencing leads to a severe defect in mitochondrial respiratory
activity. More specifically, we demonstrate that down-regula-
tion of this enzyme causes a decrease of the 16S mt-rRNA,
resulting in a defective biogenesis of the large mitochondrial
ribosomal subunit (mt-LSU) and, as a consequence, a severe
reduction ofmitochondrial protein synthesis. Finally, we report
that RPUSD4 interacts physically with the 16S mt-rRNA, mt-
tRNAMet, and mt-tRNAPhe, and we present evidence that indi-
cates that RPUSD4 is responsible for the formation of pseudou-
ridine in the mt-tRNAPhe.
Results
To extend our knowledge of MRG-associated proteins and
by inference of MRG function, we used a microscopy-based
approach as schematically presented in Fig. 1A. Because by def-
inition allMRGs containRNA,we first generated a list of poten-
tial mitochondrial RNA-binding proteins by comparing the
previously published lists of human RNA-binding proteins
(16, 17) with the total human mitochondrial proteome as
defined by Mitocarta 2.0 (18). This generated an initial data-
base of 207 potential mitochondrial proteins able to bind RNA
(supplemental Fig. S1), and examination of this list revealed
several functional classes of proteins. As our goal was to extend
our understanding of the range of processes that take place
within MRGs, we selected representative members from each
functional class for further analysis. To this list, we added a
number of other mitochondrial proteins, which although not
necessarily binding directly to RNA appeared from previous
studies to play a role inmitochondrial gene expression (supple-
mental Fig. S1). A total of 35 potential MRG candidates were
selected for which the cDNAs were generated and cloned into
an expression vector incorporating a C-terminal FLAG tag.
Each of the resulting constructs was then used to transfect
HeLa cells to investigate the submitochondrial localization of
their products. Proteins were classified as MRG components
based on the formation of distinct foci and co-localization with
the established MRG component FASTKD2 (19, 20) (Fig. 1B).
From this analysis, we identified 12 new MRG-associated pro-
teins (Table 1), including proteins involved in RNA processing
(FASTKD1, PTCD1, and PTCD2), RNAmodification (TFB1M,
TRUB2, RPUSD3, and RPUSD4), mitoribosome assembly
(ERAL1 and NOA1/C4orf14), and structural components of
mitoribosome (MRPL47, MRPS7, and MRPS9). Interestingly,
some of the novel MRG-associated proteins (ERAL1, PTCD1,
RPUSD3, and TRUB2) also emerged to physically interact
with the already known MRG protein components FASTK,
FASTKD2, GRSF1, and MRPP1 in co-immunoprecipitation
experiments (supplemental Fig. S2 and supplemental Table S1).
From these observations, we can confirm that the MRGs con-
tain proteins participating in almost all aspects of mitochon-
drial gene expression.
From the list of the proteins specifically associated with
MRGs, we selected three poorly characterized proteins,
TRUB2, RPUSD3, and RPUSD4, which belong to a group of five
mitochondrial pseudouridine synthases (see the Introduction).
To determine whether MRG localization is a general feature of
this protein family, we investigated the submitochondrial local-
ization of each of the five enzymes (TRUB2, RPUSD3, RPUSD4,
PUS1, and PUSL1) by immunofluorescence. For this, each of
these enzymes was tagged with a FLAG peptide at the C termi-
nus and expressed at a low level in 143B cells. We observed a
clear enrichment of RPUSD3, RPUSD4, and TRUB2 in MRGs,
whereas neither PUS1 nor PUSL1 appeared to be specifi-
cally enriched in discrete foci (Fig. 2A). We conclude there-
fore that the submitochondrial localization of the pseudou-
ridine synthases is a specific property of each member of the
family.
In the present study, we concentrated primarily on RPUSD4.
To confirm the mitochondrial localization of the endogenous
protein, we performed subcellular fractionation and alkaline
sodium carbonate extraction. The results of these experiments
demonstrated that RPUSD4 is a mitochondrial protein not
associatedwithmembranes (Fig. 2,B andC). In agreement with
its MRG localization, proteinase K digestion showed that the
endogenous RPUSD4 was protected from digestion in intact
mitochondria and mitoplasts but not in permeabilized mito-
chondria (Fig. 2D). Taken together, these data show that
RPUSD4 is a mitochondrial matrix protein associated with
mitochondrial RNA granules.
To study the function of RPUSD4, our initial approachwas to
disrupt the gene in 143B cells using the CRISPR/Cas9 technol-
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ogy. However, we were unable to obtain a complete homozy-
gous knock-out, suggesting that RPUSD4 could be an essential
gene. In agreement with this conclusion, RPUSD4 was among
the recently published list of human essential genes (21). Nev-
ertheless, we obtained two viable clonal lines, both of which
were found to carry a nonsense mutation in one allele together
with a second mutation in the other allele. In one case, this was
a point mutation, and in the other it was a 21-nt deletion (sup-
plemental Fig. S3A). Both mutations are in exon 1 in the region
encoding the mitochondrial targeting signal, although neither
FIGURE 1. Identification of RNA-binding proteins associated with MRGs. A, schematic representation of the approach used to identify new MRG compo-
nents. B, representative confocal images of different classes of MRG-associated proteins. HeLa cells were transfected with expression plasmids encoding the
FLAG-tagged proteins as indicated. Mitochondria were stained using MitoTracker Deep Red FM (in blue). The cells were immunolabeled with anti-FLAG and
anti-FASTKD2 as an MRG-specific marker.White boxes indicate the regions shown at higher magnification. Scale bars are 10 m.
TABLE 1
List of novel MRG components
FAST, Fas-activated serine/threonine.
Symbol Gene name Function
ERAL1 GTPase Era, mitochondrial tRNAs Mitoribosome assembly
FASTKD1 FAST kinase domain-containing protein 1 RNA processing
MRPL47 Mitochondrial ribosomal protein L47 Ribosomal subunit
MRPS7 Mitochondrial ribosomal protein S7 Ribosomal subunit
MRPS9 Mitochondrial ribosomal protein S9 Ribosomal subunit
NOA1 (C4orf14) Nitric oxide-associated protein 1 Mitoribosome assembly
PTCD1 Pentatricopeptide repeat-containing protein 1, mitochondrial RNA processing
PTCD2 Pentatricopeptide repeat-containing protein 2, mitochondrial RNA processing
RPUSD3 RNA pseudouridylate synthase domain-containing protein 3 RNA modification
RPUSD4 RNA pseudouridylate synthase domain-containing protein 4 RNA modification
TFB1M Dimethyladenosine transferase 1, mitochondrial RNA modification
TRUB2 Probable tRNA pseudouridine synthase 2 RNA modification
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prevented mitochondrial localization of the mutant protein
(supplemental Fig. S3, A and B). In agreement with the geno-
type, we observed a reduction of RPUSD4 protein level of about
50% (supplemental Fig. S3B).
In the light of these findings, we decided to pursue an alter-
native approach in which we performed inducible shRNA-me-
diated knockdown of RPUSD4 in 143B cells. Upon induction of
the shRNA expression, we obtained 80% reduction in the
steady-state level of the RPUSD4 protein (Fig. 3, A and B). To
investigate the effect of RPUSD4 depletion on mitochondrial
function, we first analyzed the steady-state level of a set of
OXPHOS subunits in RPUSD4-silenced cells by Western blot-
ting and observed an overall reduction in the subunits of respi-
ratory complexes in RPUSD4-depleted cells (Fig. 3, C and D).
We then measured the oxygen consumption rate in permeabi-
lized cells silenced for RPUSD4 and in control cells. Consis-
tent with the previous result, we observed a decrease in
OXPHOS activity (Fig. 3, E and F). Interestingly, the clones in
which RPUSD4 was partially depleted through CRISPR/Cas9
mutagenesis also showed reduced levels of respiratory com-
plex subunits, which could be restored by overexpression of
RPUSD4 (supplemental Fig. S3C), and reduced respiratory
activity (supplemental Fig. S3, D and E). Together, these exper-
iments reveal that RPUSD4 is necessary for mitochondrial
respiration.
We next investigated whether the impairment of OXPHOS
in cells depleted for RPUSD4 was due to a defect in mitochon-
drial gene expression. Mitochondrial protein synthesis was
monitored in 143B cells following incorporation of [35S]me-
thionine and [35S]cysteine and revealed a marked decrease in
global mitochondrial translation in RPUSD4-depleted cells
(Fig. 4, A and B).
To determine whether this decrease in mitochondrial pro-
tein synthesis could be due to a defect in transcription and/or
mtRNA processing, we analyzed the steady-state level of a rep-
resentative subset of mitochondrial transcripts by Northern
blotting. No significant effect on the levels of mitochondrial
protein coding mt-mRNAs was detected (Fig. 4C). In contrast,
we observed amarked reduction in the level of 16Smt-rRNA in
RPUSD4-depleted cells even though the level of 12S mt-rRNA
was unaffected (Fig. 4D). Taken together, these results argue
against the hypothesis that the reduced mitochondrial transla-
tion in RPUSD4-depleted cells is due to a global defect in the
synthesis or processing of polycistronic transcripts but rath-
er suggest a specific role of RPUSD4 in stabilizing the 16S
mt-rRNA.
Because the silencing of RPUSD4 caused a substantial
decrease in the level of the 16Smt-rRNA, we hypothesized that
RPUSD4 could be involved in the assembly of the large 39S
mt-LSU. To test this, we analyzed the steady-state levels of rep-
resentative mitoribosomal proteins (MRPs). Western blotting
revealed a marked reduction in the steady-state levels of 39S
FIGURE 2. Submitochondrial localization of the mitochondrial pseudou-
ridine synthases.A, confocal analysis of each of the fivemitochondrial pseu-
douridine synthases. 143B cells were transfected with expression plasmids
encoding the FLAG-tagged proteins indicated. Mitochondria were stained
usingMitoTracker Deep Red FM (in blue). The cells were immunolabeledwith
anti-FLAG and anti-FASTKD2 as anMRG-specificmarker.White boxes indicate
the regions shown at higher magnification. Scale bars are 10m. B, subcellu-
lar fractionation of 143B cells and analysis by Western blotting show enrich-
ment for the endogenous RPUSD4 in the mitochondrial fraction. Total cell
lysate (T), mitochondrial (M), and cytosolic (C) fractions were assessed for
purity using -tubulin and VDAC1 as cytosolic and mitochondrial markers,
respectively. C, immunoblotting analysis of total isolated 143Bmitochondria
(T) or the supernatant (S) and pellet (P) fractions following alkaline sodium
carbonate (Na2CO3) extraction.mtHSP70 and prohibitin (PHB) aremarkers for
the mitochondrial matrix and mitochondrial membranes, respectively. D,
immunoblot analysis of isolated 143B mitochondria after proteinase K (PK)
accessibility test. Mitochondria were left untreated, swollen to rupture of the
outer membrane, or lysed in Triton X-100 prior to treatment with proteinase
K. mtHSP70 is a mitochondrial matrix protein, Smac/DIABLO is an intermem-
brane space protein, and TOM20 is amitochondrial outermembrane protein.
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FIGURE 3.RPUSD4 is required formitochondrial respiration. A, shRNA-mediated knockdownof RPUSD4. Immunoblotting analysis shows a decreased level
of RPUSD4 after 7-day induction (100 ng/ml doxycycline) of shRNA (shRPUSD4). The empty vector (pLKO e.v.) was used as a control for doxycycline treatment,
andmtHSP70 was used as a loading control. B, densitometric quantification of the immunoblot shown in A. RPUSD4 values were normalized tomtHSP70 and
expressed as -fold change relative to the pLKO control. Data for the mean values are from three independent experiments; error bars represent S.D. p values
were calculated using Student’s t test.C, SDS-PAGE analysis shows reduced steady-state levels of respiratory chain components in RPUSD4-silenced 143B cells.
Western blotting membranes were probed with an antibody mixture specific for members of each OXPHOS complex. mtHSP70 and -tubulin were used as
loading controls. Due to differences in the signals for the respiratory chain subunits, high and low exposures of the blot are presented. D, densitometric
quantification of the data shown in C. The values obtained for each of the OXPHOS subunits were normalized to the values obtained for mtHSP70 and
expressed as -fold change relative to thepLKOe.v. control cells treatedwithdoxycycline. Datawereobtained from three independent experiments, andmeans
are indicated; error bars represent S.D. p values were calculated using Student’s t test. E, RPUSD4 silencing impairs mitochondrial respiration. Representative
profiles of oxygen consumption rates (OCR) in the XF PlasmaMembrane Permeabilizer reagent-permeabilized cell lines are indicated. Assays were performed
in the presence of pyruvate (10mM) andmalate (1 mM) as carbon sources, and the following compounds were injected at the times indicated by vertical lines:
carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP; 2M), succinate (10mM) and rotenone (1M), and antimycin A (1M). All measurements were
made in the presence of oligomycin (1 M) to inhibit ATP-linked respiration. Data are represented as means  S.D. F, oligomycin-sensitive respiration was
normalized to antimycin A-driven respiration and expressed as percentage of respiration relative to control (pLKO e.v.). Data from three independent exper-
iments are represented as means; error bars represent S.E. p values were obtained using Student’s t test. SDH, succinate dehydrogenase.
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FIGURE 4. Silencing of RPUSD4 affectsmitochondrial protein translation by decreasing the 16S ribosomal RNA. A, 35S labeling of de novomitochondrial
protein synthesis in RPUSD4-silenced 143B cells with a region of the Coomassie Blue-stained gel (CBS) shown as a loading control. B, phosphorimaging
quantificationprofile of thebands shown inA.C, Northernblotting analysis of total RNAextracts fromRPUSD4-silenced143B cells (shRPUSD4) and control cells
(pLKO e.v.) probed for the RNA sequences as indicated. Cytosolic 7SL RNA was used as a loading control. D, densitometric quantification of the results for the
rRNAs shown in C. The values for 16S and 12S rRNAswere normalized to the value obtained for the 7SL RNA and expressed as the -fold changewith respect to
the value obtained for pLKO e.v. cells treated with doxycycline. The combined data from four independent experiments are shown as means; error bars
represent S.D. p values were obtained using Student’s t test. CYB, cytochrome b.
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mt-LSU proteins MRPL45, MRPL11, MRPL3, and MRPL24,
whereas no differences were observed for the 28S small subunit
(mt-SSU) proteins DAP3 and MRPS27 (Fig. 5, A and B). To
investigate the consequences on the mt-LSU, we performed
isokinetic sucrose gradients on control and RPUSD4-silenced
143B cell lysates. In control cells, RPUSD4was found to co-sed-
iment specifically with the mt-LSU but not with the mt-SSU
(Fig. 5C). However, when RPUSD4 was silenced, we observed a
marked reduction in the levels of the mt-LSU assembled with
no major changes in the sedimentation profile of the mt-SSU
(Fig. 5C). These results, together with the decrease of the 16S
mt-rRNA level, suggest that RPUSD4may interact directlywith
the 39Smt-LSU, playing an essential role in its assembly and/or
stability possibly through the pseudouridylation of the 16S
mt-rRNA.
To provide further insight into possible RPUSD4 RNA
substrates, we performed UV cross-linking and immunopre-
cipitation experiments followed by high throughput RNA
sequencing (HITS-CLIP), on the lysate of 143B cells expressing
a FLAG-tagged version of RPUSD4. A highly selective subset of
mitochondrial transcripts was found to interact with RPUSD4,
including most prominently mt-tRNAPhe, the 16S mt-rRNA,
FIGURE 5.RPUSD4 co-migrateswith themt-LSUand is essential for its biogenesis.A, immunoblotting analysis of the steady-state levels of severalMRPs in
143B cells expressing shRPUSD4 or pLKO e.v. following doxycycline induction. Western blottingmembranes were probedwith antibodies against proteins of
themt-LSU ormt-SSU as indicated. TOM20was used as a loading control. B, densitometric quantification of the data shown in A. MRP values were normalized
to TOM20 values and expressed as the -fold change with respect to the pLKO e.v. control cells treated with doxycycline. Data from three independent
experiments are represented asmeans; error bars represent S.D.p valueswere obtainedusing Student’s t test.C, sucrose gradient sedimentation to analyze the
distribution of RPUSD4 andmitoribosomal proteins. Cell lysates of doxycycline-induced 143B cells expressing the pLKO e.v. (top) or shRPUSD4 (bottom) were
separated through 10–30% (w/v) isokinetic sucrose gradients and fractionated. The fractions were analyzed byWestern blotting using antibodies specific for
endogenous RPUSD4, a component of mt-LSU (MRPL3 or MRPL11), or a component of mt-SSU (DAP3).
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and mt-tRNAMet (Fig. 6A). Because HITS-CLIP generates pro-
tected sequence tags of about 30 nt, we were able to map the
RPUSD4 binding sites in each of these transcripts. For the mt-
tRNAPhe gene (MT-TF) and mt-tRNAMet gene (MT-TM), this
analysis revealed a clear enrichment for the regions containing
the pseudouridine at universal tRNA sites 39 and 50, respec-
tively (Fig. 6, B and D). In contrast, the majority of the reads
obtained for the 16S gene (encoded by RNR2 gene) did notmap
to the region corresponding to the known 1397 site but to a
site100 nt further downstream (Fig. 6C). To extend the anal-
ysis of RPUSD4 activity on the two identified mt-tRNAs, we
performed primer extension experiments in the presence of
N-cyclohexyl-N-(2-morpholinoethyl)carbodiimide metho-p-
toluenesulfonate (CMC) followed by alkali treatment, which is
known to selectively modify, blocking the reverse transcrip-
tion (22). We could detect a significant reduction of39 in the
mt-tRNAPhe when RPUSD4 was depleted (Fig. 6E). As a con-
trol, we analyzed the mt-tRNAGly, which also presents a pseu-
douridine at universal position 39; however, no differences
were observed for this mt-tRNA in pseudouridylation of posi-
tion 29 and, more interestingly, position 39 (Fig. 6F), consistent
with the HITS-CLIP results that did not reveal any RPUSD4/
mt-tRNAGly interaction. Finally, we analyzed the mt-tRNAMet,
which was found greatly enriched in our RPUSD4 HITS-CLIP
experiment. The mt-tRNAMet contains two different pseudou-
ridylation sites: 27, which is known to be modified by PUS1
enzyme (10, 13), and50 for which the responsible enzyme is
still unidentified (10). We could not observe any differences in
the modification of 27 or of 50 for this mt-tRNA in
RPUSD4-silenced cells (Fig. 6G), suggesting that RPUSD4 is not
the enzyme responsible for the generation of the in position
50.
To investigate the role of 39 in mt-tRNAPhe, we first ana-
lyzed the steady-state level of this mt-tRNA as well as mt-
tRNAMet and mt-tRNAVal in RPUSD4 knockdown cells. How-
ever, we could not observe any substantial changes (Fig. 7A).
Next, we assayed the impact of the reduced levels of 39 on
aminoacylation of mt-tRNAPhe by high resolution Northern
blotting of RNA isolated from RPUSD4-depleted cells. The use
of low pH throughout the procedure allowed for distinction
between the aminoacyl-tRNA and the uncharged tRNA. We
did not detect any substantial changes in the ratio between the
aminoacylated and deacylated forms of mt-tRNAPhe (Fig. 7B).
Also, no changes in aminoacylation were detected in control
FIGURE 6. RPUSD4 interacts with the 16S rRNA,mt-tRNAMet, andmt-tRNAPhe andmodifies the latter. A, HITS-CLIP readsmapped tomtDNA represented
on the x axis (mt-tRNA in black, mt-mRNAs in dark orange, and mt-rRNAs in light orange). B–D, detailed view of the reads mapped to mt-tRNAPhe (TM-TF), 16S
(RNR2), and themt-tRNAMet (TM-MT) regions. On the x axis are the nucleotide positions for each gene.Dashed lines indicate the known pseudouridylation sites
(the putative RPUSD4 pseudouridylation sites are indicated in black, and the others are in dark gray). E–G, primer extension experiments on RNA treated with
CMC/OH to map pseudouridines. Total RNA from pLKO e.v.- or shRPUSD4 (shRNA)-expressing cells was treated with CMC/OH and used to perform reverse
transcription primer extension using specific primers for mt-tRNAPhe (E), mt-tRNAGly (F), and mt-tRNAMet (G). Positions of pseudouridine and other RNA
modifications are indicated for each panel (the putative pseudouridylated sites are indicated in black, the other pseudouridines are in dark gray, and all the
other modifications are indicated in light gray). Low and high contrast images are presented to facilitate the visualization of low intensity signals.
FIGURE 7.Defective pseudouridylation of mt-tRNAPhe does not affect its stability or its aminoacylation. A, high resolution Northern blotting analysis of
total RNA extracts fromRPUSD4-silenced 143B cells (shRPUSD4) and control cells (pLKO e.v.) probed formt-tRNAMet, mt-tRNAVal, andmt-tRNAPhe. Cytosolic 5S
rRNA was used as a loading control. B, analysis of aminoacyl mt-tRNAs by high resolution Northern blotting of total RNA from pLKO e.v.- or shRPUSD4-
expressing cells isolated under acid conditions. Where indicated the RNA was treated with alkali (OH) to deacylate tRNAs. Membranes were probed for
mt-tRNAPhe,mt-tRNAMet, andmt-tRNALeu(UUR). Densitometryprofiles arepresented for eachmt-tRNAon the right sideof the respectiveblot.A.U., arbitraryunits.
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mt-tRNAMet and mt-tRNALeu(UUR) (Fig. 7B). Taken together,
we conclude that RPUSD4 physically interacts with mt-tRNAPhe,
16S mt-rRNA, and mt-tRNAMet. We also demonstrate that
RPUSD4 is responsible for the formation of39 in mt-tRNAPhe
and provide evidence that this modification is not crucial for
the regulation of steady-state levels or aminoacylation of
mt-tRNAPhe.
Discussion
To identify novel protein components of RNA granules, we
used a microscopy-based approach to screen a group of mito-
chondrial proteins potentially involved in different aspects of
mitochondrial gene expression. Twelve proteins of different
functional classes have been specifically localized to these
structures and represent newly described components of
MRGs. The functional diversity of these MRG components
supports the earlier conclusion that multiple steps in mito-
chondrial gene expression take place within this compact sub-
mitochondrial compartment (15). The newly identified pro-
teins are implicated inmtRNA processing (FASTKD1, PTCD1,
andPTCD2),mtRNAmodification (TFB1M,TRUB2, RPUSD3,
and RPUSD4), mitoribosome assembly (ERAL1 and NOA1/
C4orf14), and mitoribosome structure (MRPL47, MRPS7, and
MRPS9). This expands the previously established list of MRG-
associated proteins that includes GRSF1 (23, 24), FASTK (20),
FASTKD2 (19, 20), FASTKD5 (19), MRPP1 (23, 25), DDX28
(26), MRM1–3 (27, 28), and MTPAP (29). Thus, we provide
further evidence thatMRGs are intimately involved in all stages
of mitochondrial gene expression from the accumulation of
newly synthesized RNA (14, 23) to the assembly of the mitori-
bosomes (19, 26, 30). Interestingly, ourmicroscopy-based anal-
ysis has also revealed that numerous other proteins are partially
enriched in the RNA granules while also being located within
the mitochondrial matrix, underlining the probable dynamic
nature of MRG protein composition. These conclusions are
based on overexpression studies that may lead to a wider distri-
bution pattern for certain proteins, although care was taken to
image only cells with low levels of recombinant protein expres-
sion. The distribution of proteins that appear to partition
between MRGs and the matrix will be confirmed in the
future by analysis of the endogenous proteins using specific
antibodies.
Among the newly identified MRG components, we focused
on three hitherto poorly characterized putative mitochondrial
pseudouridine synthases, RPUSD3, RPUSD4, and TRUB2.
Consistent with our results showing specific localization of
these three proteins to MRGs, Arroyo et al. (31) showed
recently that these same three proteins together with FASTKD2,
Neugrin (NGRN), and WBSCR16 constitute a “functional
module” that is able to regulate the level of 16S mt-rRNA
and, more generally, the capacity for mitochondrial transla-
tion. Interestingly, two other members of the mitochondrial
pseudouridine synthase family, PUS1 and PUSL1, do not
appear to localize specifically to MRGs. However, as dis-
cussed above, definitive conclusions in this case must await
analysis of the endogenous proteins.
In this study, we focused on RPUSD4, and we provide the
first detailed characterization of this protein. Using a CRISPR/
Cas9 gene disruption approach, we found that 143B cells car-
rying a homozygous deletion of RPUSD4 are not viable, sug-
gesting an essential role of this protein in cell survival. To
investigate the function of RPUSD4 more in detail, we used an
inducible shRNA approach, which reduced the protein level to
20% of control. Under these conditions, we observed a signif-
icant decrease in the levels of certain subunits of the OXPHOS
systemand a substantial reduction in the respiratory capacity of
cells. A similar phenotype was observed in the CRISPR/Cas9-
generated heterozygous mutants in which RPUSD4 expression
was reduced to approximately 50%. This phenotype could be
rescued by re-expression of RPUSD4 to physiological levels in
the heterozygous cells, thus demonstrating that the observed
reduction in mitochondrial respiration is specific to the
heterozygosity. These data are in full agreementwith the recent
CRISPR/Cas9 screen performed by Arroyo et al. (31), indicat-
ing that RPUSD4 is among the genes essential for OXPHOS.
Here we show that the respiratory defect in RPUSD4-de-
pleted cells is a consequence of impaired mitochondrial trans-
lation and not the result of a general defect in expression of
mt-RNAs. We found that the only mtRNA to be affected by
knockdown of RPUSD4 is the 16Smt-rRNAwith no significant
effect exerted on the levels of the 12S mt-rRNA andmt-tRNAVal,
which are both present on the same polycistronic mtRNA pre-
cursor, or on any of the other mt-tRNAs examined. From these
results, we hypothesized that the observed phenotype wasmost
likely due to increased degradation of the 16S mt-rRNA rather
than to a global defect in synthesis or processing of the polycis-
tronicmtRNA. Furthermore, our analysis ofmitoribosome bio-
genesis indicated specific impairment of the mt-LSU, consis-
tent with our data that RPUSD4 was found to co-migrate with
the mt-LSU but not with the mt-SSU. Finally, our HITS-CLIP
analysis demonstrated a direct interaction of RPUSD4 with the
16S mt-rRNA. Taken together, these results suggested that
RPUSD4 is responsible for pseudouridylation of the 16S mt-
rRNA, and this constitutes an essential step in the assembly
of the mitoribosome. In the absence of RPUSD4, the 16S mt-
rRNA would not be pseudouridylated, and consequently cor-
rect assembly of the mt-LSU would be impaired, leading to the
degradation of its components. Although the 16Smt-rRNAwas
previously found to be pseudouridylated at position 1397 (11,
12), our HITS-CLIP analysis revealed that RPUSD4 binds at a
site 100 nt downstream of this site. Interestingly, the three-
dimensional model of 16S mt-rRNA proposed by Greber et al.
(32) shows that the region we found directly associated with
RPUSD4 is in close proximity to the domain where the pseu-
douridylation site resides. In agreement with our results,
Antonicka et al. (33) very recently showed that RPUSD4 plays a
direct role in the modification of the 16S mt-rRNA at position
1397.
In addition to the 16S mt-rRNA, our HITS-CLIP data iden-
tified a further two binding sites. These revealed mt-tRNAPhe
and mt-tRNAMet as specific interactors for RPUSD4. To con-
firm these data and to investigate a direct role of RPUSD4 in
modifying these two mt-tRNAs, we performed primer exten-
sion analyses following treatment with CMC and alkali, which
modifies pseudouridines and prevents readthrough of the
reverse transcriptase. We were able to demonstrate that
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RPUSD4 is responsible for the formation of 39 on mt-
tRNAPhe. This appears to be specific for mt-tRNAPhe be-
cause no changes in modification of39 on mt-tRNAGly were
observed. Curiously, despite the greatly larger number of reads
mapped in our HITS-CLIP for mt-tRNAMet at precisely the
50 site, depletion of RPUSD4 did not result in loss of pseu-
douridylation at this site. This raises the possibility that
RPUSD4 may interact physically with mt-tRNAMet without
being the enzymedirectly involved in itsmodification. Thus, we
suggest that selectivity of RPUSD4 for its target mt-tRNA is
determined not only by the position of the residue within the
mt-tRNA structure but also by sequence differences around the
region of pseudouridylation. Despite the reduced levels of39
in the mt-tRNAPhe, we did not observe any differences in the
steady-state level of this mt-tRNA, suggesting that 39 does
not play a role in the stability of this mt-tRNA. Moreover, we
did not observe any substantial differences in its aminoacy-
lation in RPUSD4-depleted cells. Thus, the significance of
the 39 modification on mt-tRNAPhe still requires further
investigation.
The mammalian pseudouridine synthases are generally clas-
sified into five families, each related to one of the five Esche-
richia coli pseudouridine synthases (TruA, TruB, TruD, RsuA,
and RluA), which are responsible for themodification of differ-
ent RNA substrates (6, 34). In human mitochondria, the pseu-
douridine synthases PUS1 and PUSL1 belong to the TruA fam-
ily, and TRUB2 belongs to the TruB family, whereas RPUSD3
andRPUSD4 aremembers of the RluA family. Interestingly, the
bacterial protein RluA is the only pseudouridine synthase that
displays a dual specificity, being able to modify both the large
23S rRNA and several tRNAs, including tRNAPhe in position 32
(35). In light of our data on RPUSD4, we suggest that pseudou-
ridylation in mammalian mitochondria has been highly con-
served throughout evolution from bacteria to human.
Experimental Procedures
Cell Culture, Transfection, and Chemicals—All cell culture
reagents and chemicals were purchased from Sigma unless
stated otherwise. Cells were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% heat-inacti-
vated fetal bovine serum (FBS), 100 units/ml penicillin, 100
g/ml streptomycin, and 2mM L-glutamine in 5%CO2 at 37 °C.
CRISPR/Cas9 cells were grown in the same medium supple-
mentedwith 110g/ml sodiumpyruvate and 50g/ml uridine.
Transfection of cells was performed using Lipofectamine LTX
(Invitrogen) according to the manufacturer’s instructions, and
cells were analyzed 16–24 h after transfection.
Generation of CRISPR/Cas9 Cells—To generate RPUSD4
knock-out cells using the CRISPR/Cas9 technology, we cloned
the following guide RNA into the pSpCas9(BB)-2A-GFP
(pX458) vector (Addgene): sense, CAC CTT GGC CGT TTC
CCC GGA TCC; antisense, AAA CGG ATC CGG GGA AAC
GGC CAA. 143B cells were transfected using Lipofectamine
LTX (Invitrogen). 48 h after transfection, GFP cells were
selected by fluorescence-activated cell sorting (FACS) using the
Beckman Coulter MoFlo Astrios, and single cells were trans-
ferred to individual wells of a 96-well plate to obtain single cell
clones. Screening of clones was performed by Sanger sequenc-
ing of the RPUSD4 gene and by Western blotting analysis.
Cloning, Viral Production, and RNA Interference—Cloning
the cDNAs for potential MRG proteins was performed by RT-
PCR using a human RNA library derived from different tissues
as template. Briefly, individual cDNAs for each gene were gen-
erated by reverse transcription using a pool of 10 gene-spe-
cific primers located immediately downstream of the coding
sequence, and aliquots of the cDNA pool were PCR-amplified
using primers designed to generate the full-length cDNA.
Unique restriction siteswere added to the 5 extremities of each
PCR primer, and the cDNAswere cloned into the pCimamma-
lian expression vector (Promega) in-frame with a C-terminal
FLAG tag. For lentiviral expression, the RPUSD4 cDNA (tran-
script variant 1) was subcloned together with the C-terminal
FLAG tag into the constitutive lentiviral expression vector
pWPT (Addgene). Stable cell lines were generated using a len-
tivirus-based procedure. Briefly, the cDNA was cloned into
pWPT and co-transfected with the lentiviral packaging plas-
mids pMD2.G and psPAX2 (Addgene) into HEK293T cells by
calcium phosphate co-precipitation. Medium containing virus
was collected 48 h after transfection and filtered using mem-
branes with a pore size of 0.45 m. The viral supernatant was
added to 70% confluent recipient cells, and transduction effi-
ciency was estimated by immunofluorescence and Western
blotting.
For RNA interference, the following shRNA sequence
against RPUSD4 (shRPUSD4) was cloned into the pLKO-
Tet-On vector (Addgene): sense, 5-CCGGGCTTCGAGTTC
ACT TGT CCT TCT CGA GAA GGA CAA GTG AAC TCG
AAG CTT TTT G; antisense, 5-AAT TCA AAA AGC TTC
GAG TTC ACT TGT CCT TCT CGA GAA GGA CAA GTG
AAC TCG AAG C. The pLKO-Tet-On empty vector was
always included as a negative control. Production of lentivirus
was performed as described above. After 48 h of infection, cells
were selectedwith 5g/ml puromycin for a further 48 h. Induc-
tion of shRNA expression was achieved following addition of
100 ng/ml doxycycline for 7 days.
Protein Co-immunoprecipitation andMass Spectrometry—A
mitochondrion-rich fraction was isolated from 143B cells sta-
bly expressing either GFP (as a control), the mitochondrial ver-
sion of FASTK-FLAG (20), FASTKD2-FLAG,GRSF1-FLAG, or
MRPP1-FLAG, and cross-link-free RNase-free FLAG immuno-
precipitation was performed as described previously (31). Pro-
teins were eluted with a 3xFLAG peptide (Sigma), precipitated
with trichloroacetic acid (TCA), and analyzed by nano-LC-
MS-MS at the proteomics core facility of the University of
Geneva. True hits were scored based on the identification of at
least three peptides per protein, an enrichment of minimum
2-fold over the GFP control (scaffold) and based on their pres-
ence in MitoCarta2.0 (18).
Immunofluorescence andMicroscopy—Immunofluorescence
analyses were performed on cells fixed in 4% paraformaldehyde
for 15 min. Cell permeabilization and blocking were done
together by incubating the fixed cells in PBS containing 0.3%
Triton X-100 and 1% preimmune goat serum for 1 h. The same
buffer was used to incubate cells with the specified primary
antibody (see antibody section below).After 2-h incubation, the
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cells were washed in PBS and incubated with the appropriate
secondary antibody conjugated with Alexa Fluor 488 or Alexa
Fluor 594 (Life Technologies). Mitochondrial networks were
stained before fixing the cells usingMitoTracker Deep Red FM
(Thermo Fisher Scientific) according to the manufacturer’s
instructions. Imaging was performed using a Zeiss LSM700
confocal microscope equipped with a 63 oil objective. All
images were imported in ImageJ and uniformly adjusted for
brightness and contrast.
Mitochondrion-rich Fraction Isolation, Proteinase K Accessi-
bility Test, and Alkali Treatment—Preparation of cytosolic,
nuclear, and mitochondrion-rich fractions; alkali treatment;
and proteinase K accessibility assays were performed as
described previously (23).
Western Blotting—Unless otherwise specified, cell lysates
were prepared by lysing cells in radioimmune precipitation
assay lysis buffer (150mMNaCl, 1% Triton X-100, 0.5% sodium
deoxycholate, 0.1% SDS, and 50mMTris, pH 8.0) for 30 min on
ice followed by removal of insoluble material by centrifugation
at 16,000  g for 10 min at 4 °C. Protein content was deter-
mined using the Bradford protein assay (Bio-Rad), and equal
amounts of protein were analyzed by SDS-PAGE. For immuno-
blotting, proteins were transferred electrophoretically to nitro-
cellulose or PVDFmembranes (GEHealthcare) and exposed to
the specified primary antibodies (see antibody section below).
The blots were further incubated with anti-goat, anti-rabbit, or
anti-mouse HRP-conjugated secondary antibodies (Dako) and
visualized using ECL.Where required, images ofWestern blot-
ting were treated for contrast enhancement and quantified
using ImageJ.
Determination of Respiratory Chain Activity—Measurement
of oxygen consumption was performed using a Seahorse XFe24
Flux Analyzer (Seahorse Biosciences). 35,000 cells were seeded
into XF24 cell culture microplates and grown overnight in
DMEMcontaining 10% FBS, 2mM L-glutamine, 25mM glucose,
and penicillin/streptomycin. Experiments were carried out at
37 °C in Mitochondrial Assay Solution (containing 70 mM
sucrose, 220mMmannitol, 10 mMKH2PO4, 5 mMMgCl2, 2 mM
Hepes, 1mMEGTA, and 0.2% fatty acid-free BSA, pH 7.2). Cells
were permeabilized with 1 nM XF Plasma Membrane Permea-
bilizer reagent (Seahorse Bioscience) and provided with 5 mM
pyruvate, 0.5 mM malate, 2 mM dichloroacetate, and 1 M oli-
gomycin for 1 h before the assay. Basal oxygen consumption
wasmeasured before further treatment. At the times indicated,
the following compounds were injected: carbonyl cyanide-4-
(trifluoromethoxy)phenylhydrazone (final concentration, 2 M),
succinate/rotenone (10 mM/1 M), and antimycin A (1 M).
Eachmeasurement loop consisted of 30 smixing, 1minwaiting,
and 2 min measuring oxygen consumption.
RNAExtraction andNorthern Blotting—RNA extraction and
Northern blotting analyses were performed as described pre-
viously (23). Briefly, total RNA was extracted using TRIzol
(Thermo Fisher Scientific). 5–10 g of RNAwere separated on
a denaturing formaldehyde 1% agarose gel for mRNAs and
rRNAs or 10% polyacrylamide gel containing 7 M urea for
tRNAs, transferred to a nylon membrane (GE Healthcare), and
UV-crosslinked to themembrane.Membraneswere hybridized
with T7-transcribed [-32P]UTP- radiolabeled riboprobes.
Hybridization was performed at 60 °C in 50% formamide, 7%
SDS, 0.2 M NaCl, 80 mM sodium phosphate, pH 7.4, and 100
g/ml salmon sperm DNA. Imaging and quantification were
performed with a phosphorimaging system (Bio-Rad) or
Typhoon imaging system (GE Healthcare). A detailed list of
primers used to transcribe the riboprobes is provided in
supplemental Table S2.
Pulse Labeling of Mitochondrial Translation—Pulse labeling
experiments to evaluate mitochondrial translation were per-
formed as described previously (23). Briefly, 143B cells were
incubated for 20 min in methionine- and cysteine-free DMEM
(Sigma) supplemented with 10% dialyzed serum and 2 mM
L-glutamine. Emetine dihydrochloride (100 g/ml) was added
for 5 min to inhibit cytosolic translation followed by addition
of 100 Ci/ml S35-labeled methionine and cysteine mixture
(PerkinElmer Life Sciences). Labeling was performed for 1 h,
and then cells were lysed. The protein content of each sample
was measured using the Bradford assay (Bio-Rad), and 50 g of
each protein sample were resolved by 15–20% SDS-PAGE.Gels
were stained with Coomassie Brilliant Blue to confirm equal
loading, then dried, and exposed. Imaging and quantification
were performed with a phosphorimaging system (Bio-Rad).
Isokinetic Sucrose Gradients for Mitoribosome Fractionation—
Isokinetic sucrose gradients were performed as described pre-
viously (36). Briefly, cell lysates (0.5–0.7mg in lysis buffer) were
loaded on to a 10–30% (v/v) linear sucrose gradient (1ml) in 50
mM Tris-HCl, pH 7.2, 10 mM magnesium acetate, 40 mM
NH4Cl, 0.1 MKCl, 1mMPMSF, and 50g/ml chloramphenicol.
Gradients were centrifuged at 39,000  g for 135 min at 4 °C
using a Beckman Optima TLX bench ultracentrifuge equipped
with a TLS55 rotor. Fractions (100 l) were collected, and pro-
teins were precipitated with TCA and analyzed by Western
blotting.
UV Cross-linking and Immunoprecipitation—HITS-CLIP
was performed as described previously (36). Briefly, 143B cells
expressing RPUSD4-FLAGwere grown to80% confluence in
4  15-cm plates, washed in PBS, and UV-irradiated at 400
mJ/cm2 in a Stratalinker (Stratagene). To ensure that only short
protected RNA species remained, cells were lysed, bound ribo-
nucleoproteins were treated with RNase T1, and RPUSD4-
FLAG was immunoprecipitated using FLAG M2 magnetic
beads (Sigma). Bound RNA was dephosphorylated and ligated
to the 3 linker. To visualize the RNA-protein complex, the
5-ends were incubated with [-32P]ATP (3000 Ci/mol;
PerkinElmer Life Sciences) and T4 polynucleotide kinase (New
England Biolabs), separated by SDS-PAGE (10% Novex precast
gels), transferred to nitrocellulose (BA-85 Whatman), and
subjected to autoradiography. For RNA isolation, ribonucleo-
protein complexes were cut from the nitrocellulose, protein
was degraded with proteinase K, and the RNAwas precipitated
following phenol/chloroform extraction. Ligation of the 5
linker, reverse transcription, and PCR amplification were per-
formed as described previously (36). The library of PCR prod-
ucts was prepared according to themanufacturer’s instructions
(Illumina) and subjected to high throughput sequencing using
the Illumina HiSeq platform. Library preparation and sequenc-
ing were performed at Fasteris (Plan-les-Ouates, Geneva).
Quality trimming and 3-end and 5-end adaptor clipping of
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sequenced reads were performed using fastx_trimmer. Reads
were aligned against the human reference genome (hg38) using
Bowtie2/Tophat2 and then visualized and quantified with Inte-
grative Genomics Viewer (IGV) (Broad Institute).
CMC/HO Modification of RNA—Total RNA from pLKO
empty vector (e.v.) and RPUSD4 shRNA 143B cells was
extracted using TRIzol (Invitrogen) according to the manufac-
turer’s instructions. After dissolution, total RNA was subjected
toCMC/alkaline (HO) treatment according to amodified ver-
sion of Bakin and Ofengand (37). Briefly, RNA was incubated
with or without 167 M CMC for 15 min at 37 °C, precipitated,
and then incubated with 50 mM Na2CO3, pH 10.4, for 2 h at
37 °C. After a final precipitation step, RNA was solubilized in
water.
Reverse Transcription Primer Extension—Reverse transcrip-
tion primer extension was performed as described previously
(38). Briefly, DNA oligonucleotides were 5-radiolabeled using
[-32P]ATP and T4 polynucleotide kinase; annealed to 1 g of
CMC/HO-modified RNA in a 10-l reaction containing 10
mM Tris-HCl, pH 8.0, and 1 mM EDTA at 80 °C for 2 min; and
cooled slowly in a PCR block. Subsequent primer extension
reactions were performed using the Omniscript RT kit (Qia-
gen) according to themanufacturer’s instructions. After adding
3 loading dye, reaction products were separated in a 12.5%
polyacrylamide gel containing 7 M urea. Dried gels were
exposed to storage phosphor screens (GE Healthcare) and
scanned using a Typhoon imaging system.
Analysis of tRNA Aminoacylation Status—mt-tRNA amino-
acylation was analyzed essentially as described previously (39).
Briefly, total RNA was extracted using TRIzol (Invitrogen)
according to the manufacturer’s instructions with the final pel-
let resuspended in 10 mMNaOAc, pH 5, to preserve aminoacy-
lation. RNA to be deacylated was resuspended in 200 mM Tris-
HCl, pH9.5, and incubated at 75 °C for 5min; then precipitated;
and resuspended in 10 mM NaOAc. Deacylated and acylation-
preserved RNA samples were loaded (2 loading dye: 8 M urea,
100 mM NaAcO pH 5, 0.05% bromphenol blue, and 0.05%
xylene cyanol) and separated on a gel containing 6.5% poly-
acrylamide, 8 M urea, and 100 mM NaAcO, pH 5, at 4 °C and
then transferred and UV-fixed to positively charged nylon
membranes (Hybond-N, GE Healthcare). Membranes were
hybridized with 32P-labeled riboprobes and washed with 1
SSC solution. Afterward, the membranes were exposed to a
storage phosphor screen and imaged as described above.
Antibodies—The following antibodieswere used in thiswork:
FLAG M2 (Sigma, F1804), FASTKD2 (ProteinTech Group,
17464-1-AP), MRPP1 (Sigma, HPA036671), GRSF1 (Sigma,
AV40382), RPUSD4 (Abcam, ab122571), VDAC1 (Santa Cruz
Biotechnology, sc-8829), -tubulin (Sigma, T4026), mtHSP70
(Thermo Fisher Scientific, MA3-028), prohibitin (Thermo
Fisher Scientific, MA5-12858), Smac/DIABLO (Enzo Life Sci-
ences, ADI-905-244-100), TOM20 (Santa Cruz Biotechnology,
sc-11415), total OXPHOS human WB antibody mixture
(Abcam, ab110411), MRPL45 (ProteinTech Group, 15682-1-
AP), MRPL11 (Cell Signaling Technology, D68F2), MRPL3
(Abcam, ab39268), MRPL24 (ProteinTech Group, 16224-1-
AP), DAP3 (Abcam, ab11928), and MRPS27 (ProteinTech
Group, 17280-1-AP).
Statistical Analyses—All data presented are the results of at
least three independent experiments and are expressed as
means S.D. or S.E. of absolute values or percentages of con-
trol. Values were analyzed for statistical significance by
Student’s t test, and exact p values are reported in each graph.
Author Contributions—Experiments were designed by S. Z., P. R.-
G., K. M., C. A. P., R. N. L., Z. M. C.-L., M. M., and J.-C. M. Experi-
ments were carried out by S. Z., P. R.-G., A. R., K. M., S. P., C. A. P.,
and A. A. J. Bioinformatics analyses were performed by N. H. The
manuscript was written and reviewed by S. Z., P. R.-G., K. M.,
A. A. J., R. N. L., Z. M. C.-L., M. M., and J.-C. M. following inputs
and suggestions from all the authors.
Acknowledgments—We thank the current and past members of the
J.-C. Martinou laboratory for helpful advice and intellectual input
during this work, in particular Chris D. Rodley for bioinformatics
contribution in the generation of the list of potential MRG compo-
nents. We also thank Dr. A. Filipovska for sharing plasmids.
References
1. Powell, C. A., Nicholls, T. J., and Minczuk, M. (2015) Nuclear-encoded
factors involved in post-transcriptional processing and modification of
mitochondrial tRNAs in human disease. Front. Genet. 6, 79
2. Van Haute, L., Pearce, S. F., Powell, C. A., D’Souza, A. R., Nicholls, T. J.,
and Minczuk, M. (2015) Mitochondrial transcript maturation and its dis-
orders. J. Inherit. Metab. Dis. 38, 655–680
3. Lightowlers, R. N., Taylor, R. W., and Turnbull, D. M. (2015) Mutations
causing mitochondrial disease: what is new and what challenges remain?
Science 349, 1494–1499
4. Hällberg, B. M., and Larsson, N. G. (2014) Making proteins in the power-
house. Cell Metab. 20, 226–240
5. Ojala, D., Montoya, J., and Attardi, G. (1981) tRNA punctuation model of
RNA processing in human mitochondria. Nature 290, 470–474
6. Spenkuch, F., Motorin, Y., and Helm, M. (2014) Pseudouridine: still mys-
terious, but never a fake (uridine)! RNA Biol. 11, 1540–1554
7. Ge, J., and Yu, Y. T. (2013) RNA pseudouridylation: new insights into an
old modification. Trends Biochem. Sci. 38, 210–218
8. Fernandez-Vizarra, E., Berardinelli, A., Valente, L., Tiranti, V., and Zevi-
ani, M. (2007) Nonsense mutation in pseudouridylate synthase 1 (PUS1)
in two brothers affected by myopathy, lactic acidosis and sideroblastic
anaemia (MLASA). J. Med. Genet. 44, 173–180
9. Rhee, H. W., Zou, P., Udeshi, N. D., Martell, J. D., Mootha, V. K., Carr,
S. A., and Ting, A. Y. (2013) Proteomic mapping of mitochondria in living
cells via spatially restricted enzymatic tagging. Science 339, 1328–1331
10. Suzuki, T., and Suzuki, T. (2014) A complete landscape of post-transcrip-
tional modifications in mammalian mitochondrial tRNAs. Nucleic Acids
Res. 42, 7346–7357
11. Schwartz, S., Bernstein, D. A., Mumbach, M. R., Jovanovic, M., Herbst,
R. H., León-Ricardo, B. X., Engreitz, J. M., Guttman, M., Satija, R., Lander,
E. S., Fink, G., and Regev, A. (2014) Transcriptome-wide mapping reveals
widespread dynamic-regulated pseudouridylation of ncRNA and mRNA.
Cell 159, 148–162
12. Ofengand, J., and Bakin, A. (1997) Mapping to nucleotide resolution of
pseudouridine residues in large subunit ribosomal RNAs from represen-
tative eukaryotes, prokaryotes, archaebacteria, mitochondria and chloro-
plasts. J. Mol. Biol. 266, 246–268
13. Patton, J. R., Bykhovskaya, Y., Mengesha, E., Bertolotto, C., and Fischel-
Ghodsian, N. (2005) Mitochondrial myopathy and sideroblastic anemia
(MLASA): missense mutation in the pseudouridine synthase 1 (PUS1)
gene is associated with the loss of tRNA pseudouridylation. J. Biol. Chem.
280, 19823–19828
14. Iborra, F. J., Kimura, H., and Cook, P. R. (2004) The functional organiza-
tion of mitochondrial genomes in human cells. BMC Biol. 2, 9
RPUSD4 Role inMitochondrial Translation
MARCH 17, 2017•VOLUME 292•NUMBER 11 JOURNAL OF BIOLOGICAL CHEMISTRY 4531
15. Jourdain, A. A., Boehm, E., Maundrell, K., and Martinou, J. C. (2016)
Mitochondrial RNA granules: compartmentalizing mitochondrial gene
expression. J. Cell Biol. 212, 611–614
16. Baltz, A. G., Munschauer, M., Schwanhäusser, B., Vasile, A., Murakawa,
Y., Schueler, M., Youngs, N., Penfold-Brown, D., Drew, K., Milek, M.,
Wyler, E., Bonneau, R., Selbach, M., Dieterich, C., and Landthaler, M.
(2012) The mRNA-bound proteome and its global occupancy profile on
protein-coding transcripts.Mol. Cell 46, 674–690
17. Castello, A., Fischer, B., Eichelbaum, K., Horos, R., Beckmann, B. M.,
Strein, C., Davey, N. E., Humphreys, D. T., Preiss, T., Steinmetz, L. M.,
Krijgsveld, J., andHentze,M.W. (2012) Insights into RNAbiology from an
atlas of mammalian mRNA-binding proteins. Cell 149, 1393–1406
18. Calvo, S. E., Clauser, K. R., and Mootha, V. K. (2016) MitoCarta2.0: an
updated inventory of mammalian mitochondrial proteins. Nucleic Acids
Res. 44, D1251–D1257
19. Antonicka, H., and Shoubridge, E. A. (2015)Mitochondrial RNA granules
are centers for posttranscriptional RNA processing and ribosome biogen-
esis. Cell Rep. 10, p920–p932
20. Jourdain, A. A., Koppen, M., Rodley, C. D., Maundrell, K., Gueguen, N.,
Reynier, P., Guaras, A. M., Enriquez, J. A., Anderson, P., Simarro, M., and
Martinou, J. C. (2015) Amitochondria-specific isoform of FASTK is pres-
ent in mitochondrial RNA granules and regulates gene expression and
function. Cell Rep. 10, 1110–1121
21. Wang, T., Wei, J. J., Sabatini, D. M., and Lander, E. S. (2014) Genetic
screens in human cells using the CRISPR-Cas9 system. Science 343,
80–84
22. Ofengand, J., Del Campo, M., and Kaya, Y. (2001) Mapping pseudouri-
dines in RNA molecules.Methods 25, 365–373
23. Jourdain, A. A., Koppen, M.,Wydro, M., Rodley, C. D., Lightowlers, R. N.,
Chrzanowska-Lightowlers, Z. M., and Martinou, J. C. (2013) GRSF1 reg-
ulates RNA processing in mitochondrial RNA granules. Cell Metab. 17,
399–410
24. Antonicka, H., Sasarman, F., Nishimura, T., Paupe, V., and Shoubridge,
E. A. (2013) The mitochondrial RNA-binding protein GRSF1 localizes to
RNA granules and is required for posttranscriptional mitochondrial gene
expression. Cell Metab. 17, 386–398
25. Bogenhagen, D. F., Martin, D. W., and Koller, A. (2014) Initial steps in
RNA processing and ribosome assembly occur at mitochondrial DNA
nucleoids. Cell Metab. 19, 618–629
26. Tu, Y. T., and Barrientos, A. (2015) The humanmitochondrial DEAD-box
protein DDX28 resides in RNA granules and functions in mitoribosome
assembly. Cell Rep. 10, p854–p864
27. Lee, K. W., Okot-Kotber, C., LaComb, J. F., and Bogenhagen, D. F. (2013)
Mitochondrial ribosomal RNA (rRNA) methyltransferase family mem-
bers are positioned tomodify nascent rRNA in foci near themitochondrial
DNA nucleoid. J. Biol. Chem. 288, 31386–31399
28. Rorbach, J., Boesch, P., Gammage, P. A., Nicholls, T. J., Pearce, S. F., Patel,
D., Hauser, A., Perocchi, F., and Minczuk, M. (2014) MRM2 and MRM3
are involved in biogenesis of the large subunit of the mitochondrial ribo-
some.Mol. Biol. Cell 25, 2542–2555
29. Wilson, W. C., Hornig-Do, H. T., Bruni, F., Chang, J. H., Jourdain, A. A.,
Martinou, J. C., Falkenberg, M., Spåhr, H., Larsson, N. G., Lewis, R. J.,
Hewitt, L., Baslé, A., Cross, H. E., Tong, L., Lebel, R. R., et al. (2014) A
humanmitochondrial poly(A) polymerase mutation reveals the complex-
ities of post-transcriptional mitochondrial gene expression. Hum. Mol.
Genet. 23, 6345–6355
30. Barrientos, A. (2015)Mitochondriolus: assemblingmitoribosomes.Onco-
target 6, 16800–16801
31. Arroyo, J. D., Jourdain, A. A., Calvo, S. E., Ballarano, C. A., Doench, J. G.,
Root, D. E., and Mootha, V. K. (2016) A Genome-wide CRISPR death
screen identifies genes essential for oxidative phosphorylation. Cell
Metab. 24, 875–885
32. Greber, B. J., Boehringer, D., Leitner, A., Bieri, P., Voigts-Hoffmann, F.,
Erzberger, J. P., Leibundgut, M., Aebersold, R., and Ban, N. (2014) Archi-
tecture of the large subunit of the mammalian mitochondrial ribosome.
Nature 505, 515–519
33. Antonicka, H., Choquet, K., Lin, Z. Y., Gingras, A. C., Kleinman, C. L., and
Shoubridge, E. A. (2017) A pseudouridine synthase module is essential for
mitochondrial protein synthesis and cell viability. EMBO Rep. 18, 28–38
34. Hamma, T., and Ferré-D’Amaré, A. R. (2006) Pseudouridine synthases.
Chem. Biol. 13, 1125–1135
35. Hoang, C., Chen, J., Vizthum,C.A., Kandel, J.M.,Hamilton, C. S.,Mueller,
E. G., and Ferré-D’Amaré, A. R. (2006) Crystal structure of pseudouridine
synthase RluA: indirect sequence readout through protein-induced RNA
structure.Mol. Cell 24, 535–545
36. Dennerlein, S., Rozanska, A., Wydro, M., Chrzanowska-Lightowlers,
Z. M., and Lightowlers, R. N. (2010) Human ERAL1 is a mitochondrial
RNA chaperone involved in the assembly of the 28S small mitochondrial
ribosomal subunit. Biochem. J. 430, 551–558
37. Bakin, A. V., and Ofengand, J. (1998) Mapping of pseudouridine residues
in RNA to nucleotide resolution.Methods Mol. Biol. 77, 297–309
38. Powell, C. A., Kopajtich, R., D’Souza, A. R., Rorbach, J., Kremer, L. S.,
Husain, R. A., Dallabona, C., Donnini, C., Alston, C. L., Griffin, H., Pyle, A.,
Chinnery, P. F., Strom, T. M., Meitinger, T., Rodenburg, R. J., et al. (2015)
TRMT5 mutations cause a defect in post-transcriptional modification of
mitochondrial tRNA associated with multiple respiratory-chain deficien-
cies. Am. J. Hum. Genet. 97, 319–328
39. Diodato, D., Melchionda, L., Haack, T. B., Dallabona, C., Baruffini, E.,
Donnini, C., Granata, T., Ragona, F., Balestri, P., Margollicci, M., Laman-
tea, E., Nasca, A., Powell, C. A., Minczuk, M., Strom, T. M., et al. (2014)
VARS2 and TARS2 mutations in patients with mitochondrial encephalo-
myopathies. Hum. Mutat. 35, 983–989
RPUSD4 Role inMitochondrial Translation
4532 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 292•NUMBER 11•MARCH 17, 2017
